Fluicell AB (publ) (STO:FLUI)
Sweden · Delayed Price · Currency is SEK 9.45
+0.45 (5.00%)
Feb 11, 2026, 3:45 PM CET
Fluicell AB Market Cap
Fluicell AB has a market cap or net worth of 12.36 million as of February 11, 2026. Its market cap has decreased by -48.57% in one year.
Market Cap
12.36M
Enterprise Value
11.37M
Revenue
13.20M
Ranking
n/a
PE Ratio
n/a
Stock Price
9.45
Market Cap Chart
Since April 18, 2018, Fluicell AB's market cap has decreased from 113.77M to 12.36M, a decrease of -89.13%. That is a compound annual growth rate of -24.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 12.36M | -10.00% |
| Dec 30, 2025 | 13.74M | -30.31% |
| Dec 30, 2024 | 19.71M | 14.60% |
| Dec 29, 2023 | 17.20M | -54.87% |
| Dec 30, 2022 | 38.12M | -85.77% |
| Dec 30, 2021 | 267.82M | 14.56% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Apr 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AcouSort AB | 45.29M |
| 2cureX AB | 44.31M |
| Nanologica AB | 35.35M |
| Guard Therapeutics International AB | 34.49M |
| Modus Therapeutics Holding AB | 34.06M |
| Aptahem AB | 20.30M |
| NanoEcho AB | 15.67M |
| Novakand Pharma AB | 15.58M |